العقول العظيمة

والإجتماع لمناقشة الأفكار

مبادرة عقول عظيمة هي مشروع  تعليمي مستمر تقوم به شركه   أوركيديا بغرض منح الفرصة لنحو 1000 طبيب عيون مصري شاب للاقتراب لوقتٍ كافٍ من أعظم العقول المصرية في مجال طب العيون، والاستفادة منهم.

"حمله "عنيك فى عنينا

إحدى حملاتنا الناجحة للمسؤولية الاجتماعية

تم إطلاقها لمكافحة العمى من خلال بحث ميداني شامل للكشف المبكر عن حالات المياه البيضاء والمياه الزرقاء.

إطلاق لوتيرانول في السوق المصري

بحضور 100 من أطباء واساتذة طب العيون في مصر

متوفر في السوق المصري 

الأن بالسوق المصرى

المجموعة الكاملة للعناية بالبشرة والشعر

لأول مرة منتجات العناية بالبشرة و الشعر من شركة أوركيديا ، بأعلى جودة يمكنك الإعتماد عليها.

تيرز جارد وحدات احادية الجرعة

متوفر الآن في السوق المصري

بولى فريش أدڤانسيد

متوفر حاليًا بالسوق المصرى


بقوة ترطيب هيالورونات الصوديوم

متوفر الان  بالسوق المصرى

Our current portfolio includes 60 ophthalmic drugs, and 8 medical devices obtain the CE marked certificates.

In addition to a rich pipeline of 60 drugs in different ophthalmic drug forms. Our CE products are registered in Germany; our authorized representative there is MDSS( Medical Device Safety Services”
We also have a portfolio of 20 food supplement and 56 cosmeceutical products, manufactured according to the latest technologies.

We are Helping to Advance Health with Clinical Trials and Vaccines Development.

Wetlab is a basic course in Phacoemulsification offered by Orchidia Pharmaceutical which is tailor-made to suit the needs of our future surgeons to provide step by step training on Phaco procedure and give them the confidence to handle their own Phaco procedures at the end of the course.

Sets The Standard For High Quality Care

Orchidia Updates



أخبار أوركيديا


Building a healthier world mean looking at the future genetics and being ready for it.


In the face of a growing street drug crisis, quick and accurate screening is a matter of life.


We care for our patients, each other, and our communities. Excellence is the standard.

Your Trusted Partner in Health care!

Our focus is on providing patients the best possible care and we’re here to help. To complement our comprehensive tests, we provide products, resources and studies to registered healthcare professionals to support our patients needs.



There is an individual variation in biological reactions in humans to medicinal products. This is why some of adverse reactions associated with the use of medicinal products cannot be detected during clinical trials.



Expansion into international markets demonstrates our commitment to support our company growth aiming to be the leading ophthalmic producer in Africa and the middle east.
Orchidia international expansion began in 2015 in Western Africa
Orchidia Pharmaceutical Ind. currently exists in 40 countries
A cornerstone of our export philosophy is to partner with the most reputable business partners/agents in each country.

Orchidia was established in 2007 with a distinguished mission of improving people’s Quality of Life

Orchidia is one of the leading ophthalmic manufacturing corporates in Egypt, with a ranked number #2 two in the ophthalmic drugs market in which 45 companies operate.
We work day and night to solve the problems that can help them move forward for those who is seeking answers!
Our employees adhere to applicable laws and regulations, as well as conduct that is consistent with our commitment to honesty, fairness, respect for people, Integrity and transparency, Innovation & creativity & Engagement.
Please feel welcome to contact our friendly reception staff with any general or medical enquiry. Our doctors will receive or return any urgent calls.
We are happy to hear from you all your suggestions, questions, or feedbacks. Our Specialty Areas

Contact our friendly staff or call us
any time

No products in the cart.